Contact Us
Drug Search Results
More Filters [+]

Bromperidol

Alternative Names: bromperidol
Latest Update: 2023-11-07
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Haloperidol Analogue

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Belgium | Chile | Germany | Italy | Korea | Luxembourg | Netherlands | Peru | Portugal

Approved Indications: None

Known Adverse Events: None

Company: Hannover Medical School
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Bromperidol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Affective Disorders, Psychotic|Schizophrenia|Psychotic Disorders

Phase 3: Depressive Disorder|Dementia|Schizophrenia|Psychophysiologic Disorders|Tic Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
GAP

P3

Terminated

Dementia|Schizophrenia|Psychophysiologic Disorders|Depressive Disorder|Tic Disorders

2017-06-28

DO 1723/1-1

P4

Completed

Affective Disorders, Psychotic|Schizophrenia|Psychotic Disorders

2016-06-22

2013-000338-37

P4

Completed

Schizophrenia

2016-06-22

APIC

P4

Terminated

Schizophrenia

None

Recent News Events

Date

Type

Title

11/07/2023

PubMed

 Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system.

06/27/2023

PubMed

 Hybrid neural network approaches to predict drug-target binding affinity for drug repurposing: screening for potential leads for Alzheimer's disease.

04/21/2022

PubMed

 The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer's Disease.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions